Clinical Trials Browser

Phase 1 × INDUSTRY × pegylated granulocyte colony-stimulating factor, human × Clear all

NCT02963389 2019-01-15

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma Patients

Phase 1 Completed

Lymphoma